About Mingwood Biotechnology BeiJing

At Mingwood, our mission is clear: to make cutting-edge medical devices accessible to everyone. Our business is built on three core pillars: Women’s and Children’s Diagnostics, Mass Spectrometry, and Orthopedics. Our journey began in 2000, when we started as an in-vitro diagnostic manufacturer, launching the BV Rapid Blue™ test reagent for gynecology—the first product of its kind to be approved in China. Since then, we've expanded our diagnostic offerings to include HPV, TCT, prenatal diagnostics, newborn screening, and more, creating a comprehensive product line for women's and children's health. In addition to our diagnostics expertise, we have successfully established a nationwide distribution network for orthopedic products, supplying trauma, joint, and spine implants, as well as consumables, to leading hospitals across the country. With the domestic market reaching maturity, we are now focused on expanding our presence globally. In 2019, we ventured into mass spectrometry solutions, which have quickly gained traction in hospitals. To date, we offer more than 60 mass spectrometry-based tests. Furthermore, we have introduced rapid dry tests to our product portfolio, reinforcing our commitment to delivering innovative and reliable solutions. At Mingwood, we are driven by a singular vision: Affordable healthcare for everyone, made possible through the power of technology and innovation.